Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics (TARA)
NASDAQ:TARA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -341.00K | $ -247.00K | $ -1.17M | $ -196.00K |
| Operating Income | $ -49.15M | $ -43.61M | $ -67.06M | $ -47.49M | $ -34.44M |
| EBITDA | $ -49.15M | $ -43.27M | $ -64.57M | $ -46.09M | $ -33.78M |
| Net Income | $ -44.60M | $ -40.42M | $ -64.81M | $ -47.13M | $ -33.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 170.29M | $ 65.58M | $ 84.37M | $ 91.23M | $ 168.60M |
| Total Assets | $ 181.45M | $ 78.95M | $ 113.29M | $ 172.60M | $ 203.16M |
| Total Debt | $ 4.48M | $ 5.47M | $ 6.38M | $ 7.24M | $ 1.09M |
| Net Debt | $ -158.31M | $ -34.12M | $ -17.74M | $ -28.48M | $ -167.51M |
| Total Liabilities | $ 14.32M | $ 10.63M | $ 11.21M | $ 10.68M | $ 3.91M |
| Stockholders' Equity | $ 167.13M | $ 68.32M | $ 102.08M | $ 161.91M | $ 199.24M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.87M | $ -37.60M | $ -26.58M | $ -35.10M | $ -24.29M |
| Operating Cash Flow | $ -35.81M | $ -37.56M | $ -26.46M | $ -34.50M | $ -23.41M |
| Investing Cash Flow | $ 19.16M | $ 53.11M | $ 14.95M | $ -98.19M | $ 2.83M |
| Financing Cash Flow | $ 139.87M | $ -91.00K | $ -90.00K | $ -228.00K | $ 189.40M |